Alvogen Pharma (India) Private Limited, a active private limited company, was established on 13 April 2010 in Bangalore, Karnataka, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U74900KA2010PTC053204. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.50 M and a paid-up capital of ₹5.12 M.
It upholds a compliant status. Employing 31 professional, Its leadership includes Divya Chandu Patel (Nominee Director), Saral Thangam (Director), Fjalar Kristjansson (Director). Past directors included Javali Sudhir Pai, Arni Hardarson, Saral Thangam. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 147/F, 8Th Main, 3Rd Block Koramangala, Bangalore, Karnataka, 560034.
U74900KA2010PTC053204
053204
13 April 2010
₹5.50 M
₹5.12 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Alvogen Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Divya Chandu Patel | Nominee Director | 01 May 2010 | Current |
| Saral Thangam | Director | 20 Sep 2014 | Current |
| Fjalar Kristjansson | Director | 13 Apr 2010 | Current |
| Aditya Nagaraj Bellur | Director | 13 Dec 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Sep 2014 | Past |
| Pramod Abcsdd | Nominee Director | 13 Mar 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Company Secretary | 31 Dec 2010 | Past |
| Pramod Abcsdd | Director | 22 Dec 2022 | Past |
| Pramod Abcsdd | Director | 20 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alvogen Pharma (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.65% increase. The company also saw a substantial improvement in profitability, with a 205% increase in profit. The company's net worth Soared by an impressive increase of 41.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Alvogen Pharma (India) had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Alvogen Pharma (India) has a workforce of 31 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Alvogen Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alvogen Pharma (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Alvogen Pharma (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Alvogen Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
Aditya Nagaraj Bellur was appointed as a Director was appointed as a Director on 13 Dec 2017 & has been associated with this company since 8 years 1 month . was recorded as a recent event.
Saral Thangam was appointed as a Director was appointed as a Director on 20 Sep 2014 & has been associated with this company since 11 years 3 months . was recorded as a recent event.
Progress on Divya Chandu Patel was appointed as a Nominee Director was appointed as a Nominee Director on 01 May 2010 & has been associated with this company since 15 years 8 months . was documented.
Fjalar Kristjansson was appointed as a Director was appointed as a Director on 13 Apr 2010 & has been associated with this company since 15 years 9 months . was recorded as a recent event.
The CIN of Alvogen Pharma (India) Private Limited is U74900KA2010PTC053204.
Alvogen Pharma (India) Private Limited is headquartered at 147/F, 8Th Main, 3Rd Block Koramangala, Bangalore, Karnataka, 560034.
Alvogen Pharma (India) Private Limited was incorporated on 13 April 2010.
The current directors of Alvogen Pharma (India) Private Limited are
The primary industry of Alvogen Pharma (India) Private Limited is Professional, Scientific And Technical.
Alvogen Pharma (India) Private Limited is unlisted.
The authorized capital of Alvogen Pharma (India) Private Limited is ₹5.50 M, and the paid-up capital is ₹5.12 M.
The compliance status of Alvogen Pharma (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX